A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: NNC0268-0965;   Drug: insulin glargine Sponsor:   Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials